BOSTON SCIENTIFIC NEUROMODULATION CORP

Boston Scientific Neuromodulation Corp specializes in the supply and support of advanced electromedical devices for neuromodulation and pain management therapies, primarily serving military and veteran healthcare systems. Their core capabilities center on the distribution and integration of implantable neurostimulation systems, including spinal cord and peripheral nerve stimulators, alongside associated clinical support infrastructure. Technical expertise includes compliance with FDA-regulated medical device protocols, sterile handling and logistics for Class III implants, and secure supply chain management for sensitive therapeutic hardware. The contractor’s key differentiator lies in its ability to deliver mission-critical neuromodulation systems with rapid turnaround for time-sensitive clinical applications, ensuring continuity of care for service members and veterans with chronic pain conditions. The Department of Defense is the primary customer, consistently procuring neuromodulation devices and pain management solutions to support battlefield injury recovery, post-deployment neurological care, and long-term rehabilitation programs. The Department of Veterans Affairs also engages the contractor for ongoing therapeutic device replenishment and clinical support, indicating a sustained partnership focused on veteran-centric pain management pathways. The contractor’s primary industry focus is under NAICS 423450, reflecting its role as a merchant wholesaler of medical devices rather than a manufacturer of end-stage hardware. This positions them as a critical link between advanced neurostimulation technology producers and federal healthcare providers, ensuring reliable access to FDA-cleared implantable systems. Their vertical specialization is in neuromodulation therapies, with a narrow but deep focus on chronic pain intervention technologies. As a 2L entity based in Valencia, CA, the company operates as a specialized medical device distributor without federal certifications. Its government market positioning is defined by its exclusive focus on high-acuity, clinically essential neurostimulation systems for DoD and VA beneficiaries, with no commercial or non-federal market presence indicated in the award history.